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Background/aim: To evaluate vitamin D levels and risk factors for vitamin D deficiency in healthy newborns and their mothers.
Materials and methods: Ninety-nine healthy pregnant women (≥37 weeks of gestation) were enrolled in the study. Previous history of
pregnancies and births, nutritional status, multivitamin supplementation, educational status, type of clothing, and the economic level
of the family were recorded. Blood samples were drawn from the mothers and the umbilical cord of the newborns to measure serum
25(OH)D3, calcium, phosphorus, and parathormone levels.
Results: While vitamin D insufficiency was identified as 62.6% in mothers, it was 58.6% in newborns; on the other hand, the incidence
of vitamin D deficiency was 18.2% and 15.2% in mothers and newborns, respectively. Maternal serum 25(OH)D3 concentrations were
not significantly related to the number of pregnancies or births, type of clothing, or the nutritional, economical, or educational status
of the family (P > 0.05).
Conclusion: These findings suggest that despite a sunny environment, maternal vitamin D deficiency and insufficiency are still
important health problems in a developed region of Turkey. Therefore, more effective vitamin D prophylaxis programs are required to
prevent vitamin D deficiency in pregnant women and their offspring.
Key words: Vitamin D, pregnancy, newborn

1. Introduction
Maternal vitamin D deficiency begins to have an impact
during the intrauterine period. Congenital rickets and
neonatal hypocalcemic seizures are the early neonatal
findings of maternal vitamin D deficiency (1,2). In mothers
with low vitamin D levels, in addition to the classical
findings of vitamin D deficiency, the risks of preeclampsia,
gestational diabetes, prematurity, and infants small for
gestational age have been found to be high (3–5). Besides
the early neonatal effects of maternal vitamin D deficiency,
long-term effects have also been reported. Irrespective
of their own vitamin D intake, children with maternal
vitamin D deficiency (especially those younger than 5
years old) have been found to exhibit asthma symptoms
at a certain time during their lives (6). Furthermore, the
mental and psychomotor development scores of children
with a maternal vitamin D level of above 30 ng/mL during
pregnancy were higher compared to children with a
maternal vitamin D level below 20 ng/mL (7). Maternal
* Correspondence: ayhanabaci@gmail.com
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vitamin D deficiency has been demonstrated to have
unfavorable metabolic effects on skeletal development
during childhood (8,9). Maternal vitamin D deficiency has
been highlighted for its negative effects on the development
of long bones in the intrauterine period and its association
with premature birth (10). To prevent these undesirable
effects of vitamin D deficiency, vitamin D prophylaxis of
400 IU/day for infants and 600–2000 IU/day for pregnant
women (recommendation of the International Association
of Endocrinology) is recommended (11,12).
In Turkey, until May 2011, a health policy on
vitamin D prophylaxis for pregnant women did not
exist; thus, under the best circumstances, the vitamin
D supplements prescribed for pregnant women were
limited to low doses (200–400 IU), amounts generally
included in commercial multivitamin preparations. Due
to the current ineffectiveness of preventive health services,
newborn babies are brought to clinics with early and late
neonatal hypocalcemic seizures due to maternal vitamin
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D deficiency. The aim of this study was to identify the
prevalence and risk factors of vitamin D deficiency in
mothers and their offspring.
2. Materials and methods
Included in the study were 99 healthy pregnant women
who presented to the Obstetrics and Gynecology Services
of the Ankara Keçiören Training and Research Hospital
with their babies, born to term with a birth weight of
>2500 g, between November 2009 and February 2010.
Information about the mothers was obtained through
a survey including questions about age, number of
pregnancies, level of education, type of clothing, type of
home in which the family resides (apartment, slum), and
socioeconomic status of the mothers. The number of
pregnancies and the duration between the pregnancies,
nutrition during the pregnancy (daily consumption of
milk, milk products, and sea food), and intake of calcium
and vitamin D supplements were recorded. Mothers who
wore headscarves or long clothing covering their arms and
legs completely were classified as veiled, and others were
classified as not veiled. Mothers were grouped according
to their skin color as white, olive, or dark.
All mothers were informed about the study in detail
and informed consent was obtained. Venous blood
samples were drawn from the mothers just before giving
birth. Umbilical cord blood was obtained immediately
after birth with double clamping of the umbilical cord.
Laboratory studies were performed on the same day
and in the same series after all samples were collected
to prevent variations within and between days. Serum
calcium (Ca), phosphorus (P), alkaline phosphatase
(ALP), and 25(OH)D3 levels were measured in the blood
samples. Serum 25(OH)D3 levels were measured using
the RIA method. A 25OH-VIT.D3-RIA-CT kit was used
(Catalog No. KIP1961, Biosource, Nivelles, Belgium).
The intraassay coefficient of variation (CV) was 5.2%–
5.3% (n = 12) and interassay CV was 3.3%–4.7% (n =
12), the measurement range was 2.1–154 ng/mL, and
the detection limit was 0.6 ng/mL for 25(OH)D3. For
mothers, a serum 25(OH)D3 level of ≤20 ng/mL was
considered vitamin D deficient (group I), 21–29 ng/mL
was considered vitamin D insufficient (group II), and ≥30
ng/mL was considered normal vitamin D status (group
III) (11). For newborns, a serum 25(OH)D3 level of <15
ng/mL was considered vitamin D deficient (group 1), 15–
20 ng/mL vitamin D insufficient (group II), and >20 ng/
mL normal vitamin D status (group III) (13).
Serum calcium (mg/dL), phosphorus (mg/dL), and
alkaline phosphatase (IU/L) levels were analyzed with an
Olympus AU 5200 autoanalyzer using Diasis Diagnostic
System (DDS) kits. Normal levels were accepted as 9–11.5
mg/dL and 8.4–10.2 mg/dL for serum total Ca in umbilical

cord blood and in adults, respectively [the intraassay CV
was 1.61%–4.59% (for concentrations of 0.94–0.96),
interassay CV was 0.48%–0.65% (for concentrations of
21–856), and detection limit was 4 mg/dL]; as 4.0–7 mg/
dL and 2.5–5 mg/dL for serum P in newborns and adults,
respectively (the intraassay CV was 0.9%–2.1%, interassay
CV was 0.6%–1.9%, and detection limit was 0.5 mg/dL); as
145–420 U/L and 65–260 U/L for serum ALP in newborns
and adults, respectively [the intraassay CV was 0.93%–
11.09% (for concentrations of 21–856), interassay CV was
0.4%–7.67% (for concentrations of 21–856), and detection
limit was 5 U/L); and as 10–65 pg/mL for parathormone
[PTH; CLSI EP17, LIAISON N-TACT PTH II Assay;
intraassay CV was 2.3%–8% (for concentrations of 7.8–
797.4), interassay CV was 5.6%–13.7% (for concentrations
of 21–260), and detection limit was <4 pg/mL for PTH].
Body weight and height of the mothers before birth
were recorded. Body mass index (BMI) was calculated by
dividing the body weight in kilograms by the square of the
height in meters.
Statistical analysis was performed using SPSS 21.0 for
Windows. The normal distribution of continuous variables
was analyzed using the Kolmogorov–Smirnov test, while
group means were compared using the Kruskal–Wallis
test. When the test statistics were found to be significant, a
nonparametric multiple comparison test (Mann–Whitney
U test) was performed to identify which group caused
the significance. Nominal variables were evaluated using
Pearson’s chi-square or Fisher’s exact test. The correlation
between the independent parameters was investigated
with Spearman correlation analysis. Data were presented
as median (minimum–maximum) and P < 0.05 was
accepted as significant.
3. Results
Among the 99 mothers included in the study, 62.6% and
18.2% were identified as having vitamin D deficiency
(group I) and vitamin D insufficiency (group II),
respectively, and 19.2% were found to have normal
vitamin D levels (group III). Among the newborns, 58.6%
and 15.2% were identified as having vitamin D deficiency
and vitamin D insufficiency, respectively, and 26.3% were
found to have normal vitamin D levels. The mean vitamin
D level of the mothers was 15.1 ± 4.4 ng/mL, while it
was 15.0 ± 10.3 ng/mL in the umbilical cord blood of
the newborns (P = 0.988). Laboratory parameters of the
mothers and the newborns are summarized in Tables 1
and 2. Six mothers (9.5%) in group I who had vitamin D
deficiency had high PTH levels, while 1 mother (5.8%) in
group II who had vitamin D insufficiency had a high PTH
level. No mothers in group III had high PTH levels. The
calcium levels of 3 mothers in group I who had high PTH
levels were lower than normal. Additionally, a significant
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Table 1. Laboratory results of the pregnant women according to the groups.
Group I
(n = 64)

Group II
(n = 17)

Group III
(n = 18)

P*

Ca (mg/dL)

8.8a
(8.1–10)

8.7
(8.2–9.3)

8.9a
(8.4–9.5)

0.016

P (mg/dL)

3.9
(1.83–5.9)

4.2
(4.0–4.5)

2.7
(2.4–2.9)

0.256

ALP (IU/L)

188
(70–353)

155
(124–186)

236
(93–379)

0.623

PTH (pg/mL)

43
(11–162)

54.2
(11.5–84.4)

47.9
(48.5–60)

0.840

Vitamin D (ng/mL)

6.0a,b
(4–13.8)

20.6b,c
(17.7–23.5)

31.5a,c
(28.9–34.2)

0.001

*: Kruskal–Wallis Test, a,b,c: Mann–Whitney U test (P < 0.05), data are given as median (minimum–maximum), Ca: calcium, P:
phosphorus, ALP: alkaline phosphatase, PTH: parathormone.
Table 2. Laboratory results of newborn umbilical cord blood according to the groups.
Group I
(n = 58)

Group II
(n = 15)

Group III
(n = 26)

P*

Ca (mg/dL)

9.6
(7.7–11.3)

9.5
(8.3–11.2)

9.3
(8.6–11.3)

0.998

P (mg/dL)

3.9
(2.6–6.6)

4.0
(3.1–5.2)

3.7
(3.2–5.4)

0.866

ALP (IU/L)

246.5
(34–740)

264
(107–537)

197.5
(67–380)

0.139

PTH (pg/mL)

43
(16–168)

48.5
(12–103)

34
(11–67)

0.174

Vitamin D (ng/mL)

8.5a,c
(4–14.8)

16.3b,c
(15–20)

28.3a,b
(21.3–39.7)

0.001

*: Kruskal–Wallis Test, a,b,c: Mann–Whitney U test (P < 0.05), data are given as median (minimum–maximum), Ca: calcium, P:
phosphorus, ALP: alkaline phosphatase, PTH: parathormone.

positive correlation between the vitamin D levels of the
mothers and the umbilical cord blood of the newborns
was detected (Spearman’s rho = 0.850, P = 0.001) (Figure).
Among the groups of different maternal vitamin D
levels (groups I, II, and III), no differences were found
in maternal age, BMI, number of pregnancies and births,
duration between the last 2 pregnancies (in years),
maternal skin color, status of veiling, education, level of
income, and type of housing (P > 0.05) (Tables 3 and 4).
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On the other hand, in the group with vitamin D deficiency
(group I), the rate of using vitamin D supplements was
statistically low compared to the other groups (groups II
and III) (P = 0.037). Although there were no statistically
significant differences in the socioeconomic status or level
of education between the groups, the level of education
and income were lower in group I, and mothers in this
group were found to be veiled and to live in slum houses at
higher rates compared to the other groups (Table 4).
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Umbilical cord vitamin D levels (ng/mL)

40.00

Spearman’s rho = 0.850, P = 0.001

30.00

20.00

10.00

Observed
0.00
0.00

40.00
10.00
20.00
30.00
Maternal vitamin D levels (ng/mL)

Linear
50.22

Figure. Correlation of vitamin D levels in mothers and umbilical
cord blood of newborns.

4. Discussion
Vitamin D deficiency in mothers and their offspring is
still an important health problem in developing countries.
The primary source of vitamin D for a newborn baby is
the vitamin D that passes transplacentally to the baby
from the mother in the intrauterine period (14). In a baby

with maternal vitamin D deficiency, findings of vitamin D
deficiency (neonatal hypocalcemia and congenital rickets)
may appear immediately after birth since the breast milk is
also a poor source of vitamin D (15). Therefore, maternal
vitamin D levels are important for both the mother and
the baby.
Currently, vitamin D intake during pregnancy and
breast-feeding has been reported to be insufficient
throughout the world. In an Irish study, 14.3%–23.7%
and 34.3%–52.6% of pregnant women were found to
have vitamin D deficiency and vitamin D insufficiency,
respectively (10). Although many reports of vitamin D
deficiency in pregnant women have been published to
date, it is still a public health problem in Turkey due to the
lack of an effective prophylaxis program directed towards
pregnant women and breast-feeding mothers. This study
aimed to perform a screening of vitamin D levels in 99
mothers and their healthy babies in Ankara, considered to
be a developed city in Turkey, to compare the results with
prior data and to reemphasize the importance of preventive
medicine services in terms of vitamin D prophylaxis in
pregnant women.
Although there is no clear consensus on the level
of maternal vitamin D deficiency, the International
Association of Endocrinology suggests a vitamin D level
of 21–29 ng/mL for vitamin D insufficiency and <20 ng/
mL as a lower limit for vitamin D deficiency (11). These
criteria were used in this study. The incidence of maternal
vitamin D deficiency was reported to be between 18% and

Table 3. Demographics of the mothers according to groups.
Group I
(n = 62)

Group II
(n = 18)

Group III
(n = 19)

P*

Mother’s age (years)

28
(19–37)

29.1
(22–42)

29
(23–37)

0.076

BMI (kg/m2)

28.3
(22.9–38.1)

28.0
(23.1–37.3)

30.0
(23.6–33.9)

0.810

Number of pregnancies

2
(1–7)

2
(2–7)

2
(2–3)

0.545

Number of births

2
(1–7)

2
(1–5)

2
(1–3)

0.572

Period of time between last 2 pregnancies (years)

3.5
(0.5–15)

4.5
(0.5–15)

5
(1–15)

0.718a

Multivitamin use (%)

58.1a,b

83.3a

83.3b

0.037

*: Mann–Whitney U Test, a,b: chi-square test (P < 0.05), data are given as median (minimum–maximum),
BMI: body mass index.
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Table 4. Maternal vitamin D levels according to socioeconomic level and educational status.
Group I
(n = 62)

Group II
(n = 18)

Group III
(n = 19)

Uneducated (%)

2 (3.2)

0 (0)

0 (0)

Primary school (%)

15 (24.2)

5 (27.8)

4 (27.2)

Middle school (%)

34(54.8)

7 (38.9)

7 (38.9)

High school (%)

8 (12.9)

3 (16.7)

1 (5.6)

University (%)

3 (4.8)

3 (16.7)

6 (33.3)

White (%)

58.1

44.4

52

Olive (%)

41.9

55.6

46.9

Dark (%)

0

0

1

43 (69.4)

9 (50)

8 (44.4)

<500 TL (%)

9 (14.5)

1 (15.6)

1 (5.6)

500–1000 TL (%)

35 (56.5)

7 (38.9)

5 (27.8)

1000–1500 TL (%)

12 (19.4)

4 (22.2)

7 (38.9)

>1500 TL (%)

6 (9.7)

6 (33.3)

5 (27.8)

Apartment (%)

19 (30.6)

5 (27.8)

6 (33.3)

Slum (%)

43 (69.4)

13 (72.2)

12 (66.7)

Variables

P

Mother’s educational status
0.111

Skin color
0.160a

Mother’s headscarf status (%)
Covered (%)

0.09

Family income level (monthly)
0.05

Type of family residence
0.937

No statistically significant differences were found in the amounts of milk, yogurt, and fish consumed
among the groups (P > 0.05). a: Chi-square test (P < 0.05).

84% in studies from different countries that accepted a
level of 25(OH)D of <10 ng/mL as vitamin D deficiency
(16–19). In the study by Andiran et al. performed in
2002 in Ankara, the rate of vitamin D deficiency (<10 ng/
mL) was found to be 46% and 80% in mothers and their
babies, respectively (20). In another study from Ankara
in 2009, vitamin D deficiency was classified as severe and
intermediate; cases with a vitamin D level of less than
11 ng/mL were defined as severe and levels between 11
and 25 ng/mL were defined as intermediate vitamin D
deficiency (14). Vitamin D deficiency was seen in 81.4% of
mothers, with 27% and 54.3% of them having severe and
intermediate types of deficiency, respectively; 64.3% of
newborns had severe vitamin D deficiency and 32.9% had
intermediate vitamin D deficiency, with a total incidence
of 97.2% (14). In a study by Pehlivan et al. performed in
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Kocaeli in 2003, vitamin D levels were found to be <16
ng/mL in 95% of the mothers and <10 ng/mL in 80% of
the mothers (12). In a recent study from İzmir performed
on 258 mothers and newborns, the incidence of vitamin
D deficiency (≤20 ng/mL) was detected to be 90.3% (21).
In the present study, 62.6% and 18.2% of the pregnant
women residing in Ankara in the district of Keçiören
(2009–2010) were found to have vitamin D deficiency and
vitamin D insufficiency, respectively, while the newborn
babies of those mothers were found to have vitamin
D deficiency and insufficiency in 58.6% and 15.2% of
the cases, respectively. The strong positive correlation
between the maternal serum and newborn umbilical cord
blood vitamin D levels was compatible with the literature
knowledge and suggested that the most important cause
of vitamin D deficiency in newborn babies was maternal
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vitamin D deficiency. Although 8 years have passed
since the study of Andiran et al. in the Ankara region,
it is obvious that up to now no change has arisen in the
maternal and newborn incidences of vitamin D deficiency.
These results suggest that pregnant and breast-feeding
women are at risk for vitamin D deficiency and that
vitamin D prophylaxis is quite important and necessary in
these groups of women. Therefore, it is imperative that the
vitamin D supplementation program in our country for
pregnant women that was implemented in May 2011 by
legislation of the Turkish Ministry of Health be supported.
The strong positive correlation between the vitamin D
levels of pregnant women and the level of vitamin D in
the umbilical cord blood has been demonstrated in many
studies, and the most important indicator of the vitamin
D levels of the newborn have been emphasized to be
maternal vitamin D levels (20–22). 25(OH)D3 transfers to
the baby during pregnancy through the placenta and, thus,
the vitamin D level of the umbilical cord blood of the baby
indicates 80%–100% of the maternal vitamin D level (22).
Similarly, Ergür et al. suggested that 25(OH)D3 levels in the
umbilical cord blood were a good predictor of the vitamin
D level in the newborn, and hence it could be a feasible
method to use in newborns that are thought to be in the
risk group for vitamin D deficiency, as it is a noninvasive
test (14). Similarly, the identification of a strong positive
correlation between maternal and umbilical cord blood
vitamin D levels was found to be compatible with the
literature findings.
The administration of vitamin D to pregnant women
is quite important for the health of both the mother and
the baby when the high prevalence of nutritional rickets
in Turkey and the immunomodulation and infectionpreventing effects of vitamin D are considered (23). There
is no consensus on how long and at what dose vitamin D
should be administered to pregnant women. The United
States Association of Endocrinology emphasizes that the
target vitamin D level should be >30 ng/mL and 1500–
2000 IU of vitamin D should be administered daily to
reach this target level (11). In a randomized, double-blind
study, pregnant women were divided into 3 groups and
were given vitamin D in 3 different doses (400 IU, 2000 IU,
and 4000 IU daily) to be started in the 12th–16th weeks
of pregnancy and to be used until delivery. As a result of
that study, vitamin D at a dose of 4000 IU was found to
be safe and to provide the required vitamin D levels, and
hence the recommendation of previous groups was found
to be inadequate (24). In Turkey, although the Ministry of
Health recommends vitamin D at a dose of 1200 IU/day for
pregnant women to be taken in the last trimester, it has been
demonstrated by many studies that this recommendation
was not implemented in the majority of pregnancies (21).
Prenatal vitamin D administration is limited to 200 IU/

day, which is generally included in multivitamins; however,
even 400 IU/day is not sufficient to provide an adequate
serum level of 25(OH)D3 during pregnancy and lactation
(24–26). Due to the lack of a national health policy on
vitamin D prophylaxis, the previous level was limited to
200–400 IU/day, which was included in the multivitamin
preparations until recently, when the Turkish Ministry of
Health provided updated recommendations in 2011. In
this study, it was accepted that the daily intake of vitamin
D was limited to 200–400 IU in patients that were taking
multivitamin supplements. In addition, the development
of deficiency in spite of multivitamin use in 58.1% of
pregnant women who had vitamin D deficiency (group I)
demonstrated that the replacement dose was inadequate
and suggested that higher doses of vitamin D prophylaxis
should be administered to pregnant women.
In this study, mothers with vitamin D deficiency were
found to have a low income and education levels, though
not statistically significant, and they were found to be more
veiled and had a higher rate of living in a slum. Pehlivan
et al. reported the risk factors for maternal vitamin D
deficiency as low socioeconomic status, inadequate
intake of vitamin D in the diet, and a covered style of
dress (12), while Andiran et al. similarly reported that
low socioeconomic status, a covered style of dress, and a
lower level of education were the risk factors for maternal
vitamin D deficiency (20). Halicioglu et al., on the other
hand, found statistically significant associations between
a covered style of dress, daily consumption of milk and
milk products, and multivitamin use in pregnancy and
maternal vitamin D levels (27). In previous studies,
insufficient exposure to sunlight during the winter months
has been reported to be an important factor contributing
to maternal vitamin D deficiency (10,14). Therefore, the
high rate of maternal vitamin D deficiency in our study
could also be related to time of blood sampling, which was
done during the winter months.
Vitamin D levels were reported to be statistically
significantly lower in the newborns of mothers who were
obese during pregnancy and in children with a high
obesity index in the neonatal period (27). In the present
study, no statistically significant differences were found
between vitamin D levels and the age of the mother, BMI,
mean number of pregnancies, number of births, duration
between the last 2 pregnancies, and rate of olive skin color
in mothers among the different groups (groups I, II, and
III). Similarly, Andiran et al. found no relation between
vitamin D levels and BMI (20).
Hypocalcemia in a newborn is the most important and
earliest sign of maternal vitamin D deficiency. Vitamin
D deficiency may result in neonatal hypocalcemia,
especially if it caused secondary hyperparathyroidism and
osteomalacia in the mother (28). It has been suggested that
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even in intermediate and severe vitamin D deficiencies,
the expected PTH increase may not occur, and the clinical
and laboratory findings of vitamin D deficiency are related
not only with the severity of the deficiency but also with
the duration of it (29). In this study, increased PTH was
identified in 6 mothers (9.5%) and in 1 mother (5.8%)
among vitamin D deficient and insufficient mothers,
respectively, and it was not observed in any of the babies.
One of the reasons for the absence of any symptomatic
cases in spite of the high prevalence of vitamin D deficiency
in mothers and their newborn babies might be due to the
short duration of the deficiency.

In conclusion, vitamin D deficiency, which was found
at high rates in mothers and their babies in this study,
impacts the health of both the mothers and babies in the
short and long terms and it continues to be a frequently
seen public health problem. The results of this study are
important in demonstrating the necessity of vitamin D
prophylaxis in pregnant women. Therefore, we suggest
that physicians inform all pregnant women about the
importance of maintaining adequate vitamin D stores
during pregnancy and breastfeeding and implement
vitamin D prophylaxis programs for risk groups for the
health of both mothers and infants.
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